Login / Signup

Respiratory Syncytial Virus-Associated Respiratory Diseases in Children and Adults.

Tobias TenenbaumJohannes LieseTobias WelteJessica Rademacher
Published in: Deutsches Arzteblatt international (2024)
The approval of new RSV-specific monoclonal antibodies and active vaccinations enables targeted prevention of RSV infection in the main population groups at risk.
Keyphrases
  • respiratory syncytial virus
  • young adults
  • cancer therapy
  • respiratory tract
  • drug delivery